Silo Pharma (SILO) Interest Expenses (2011 - 2026)
Silo Pharma (SILO) posted Interest Expenses of $155688.0 for Q1 2026, up 663.18% sequentially from $20400.0 in Q4 2025, and down 11.68% YoY from $176273.0 in Q1 2025.
Silo Pharma (SILO) Interest Expenses (2011 - 2026) Analysis & Trends
Silo Pharma has reported Interest Expenses for 13 years, with the latest figure at $155688.0 in Q1 2026.
- Quarterly Interest Expenses fell 11.68% year-over-year to $155688.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $155688.0 (down 11.68% YoY) and the FY2025 annual result came in at $4.8 million, up 30.47% from the prior year.
- Interest Expenses rose to $155688.0 in Q1 2026 per SILO's latest filing, from $20400.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $1.9 million in Q2 2024 and troughed at $120.0 in Q4 2022.
- A 5-year average of $221982.2 and a median of $71190.0 in 2022 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2022 and 2024: Interest Expenses slumped 100.0% in 2022, then jumped 15213.19% in 2024.
- Over 5 years, Interest Expenses stood at $120.0 in 2022, then jumped by 127.5% to $273.0 in 2023, then increased by 0.37% to $274.0 in 2024, then surged by 7345.26% to $20400.0 in 2025, then soared by 663.18% to $155688.0 in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $155688.0, $20400.0, and $104440.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | Silo Pharma | 2.92 Mn | 2.92 Mn | - | 2,865.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 146,875.00 |
| Jun 30, 2026 | 146,875.00 |
| Mar 31, 2026 | 155,688.00 |
| Mar 31, 2026 | 155,688.00 |
| Dec 31, 2025 | 20,400.00 |
| Dec 31, 2025 | 20,400.00 |
| Sep 30, 2025 | 104,440.00 |
| Sep 30, 2025 | 104,440.00 |
| Jun 30, 2025 | 164,500.00 |
| Jun 30, 2025 | 164,500.00 |
| Mar 31, 2025 | 176,273.00 |
| Mar 31, 2025 | 176,273.00 |
| Dec 31, 2024 | 274.00 |
| Dec 31, 2024 | 274.00 |
| Sep 30, 2024 | 182,458.00 |
| Sep 30, 2024 | 182,458.00 |
| Jun 30, 2024 | 1.88 Mn |
| Jun 30, 2024 | 1.88 Mn |
| Mar 31, 2024 | 827,125.00 |
| Mar 31, 2024 | 827,125.00 |